Protein N-arginine methyltransferase 5 promotes the tumor progression and radioresistance of nasopharyngeal carcinoma

Yang,Daoke; Liang,Tiansong; Gu,Yue; Zhao,Yulin; Shi,Yonggang; Zuo,Xiaoxiao; Cao,Qinchen; Yang,Ya; Kan,Quancheng

doi:10.3892/or.2015.4513

Protein N-arginine methyltransferase 5 promotes the tumor progression and radioresistance of nasopharyngeal carcinoma

Authors:
- Daoke Yang
- Tiansong Liang
- Yue Gu
- Yulin Zhao
- Yonggang Shi
- Xiaoxiao Zuo
- Qinchen Cao
- Ya Yang
- Quancheng Kan
View Affiliations

Affiliations: Department of Radiation Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University School of Medicine, Zhengzhou, Henan 450000, P.R. China
Published online on: December 24, 2015 https://doi.org/10.3892/or.2015.4513
Pages: 1703-1710

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Radiotherapy resistance is the main cause of the the poor prognosis of some nasopharyngeal carcinoma (NPC) patients. Yet, the exact mechanism is still elusive. In the present study, we explored the clinical and biological role of protein arginine methyltransferase 5 (PRMT5) in NPC. Our results revealed that PRMT5 was overexpressed in NPC tissues when compared with that in adjacent non-tumor tissues by quantitative RT-PCR and immunoblotting. High expression of PRMT5 was correlated with adverse outcomes of NPC patients as determined by the scoring of a tissue microarray. Silencing of PRMT5 promoted the radiosensitivity of 5-8F and CNE2 cells as determined by cell proliferation and colony formation assays. Furthermore, fibroblast growth factor receptor 3 (FGFR3) was identified as one of the downstream targets of PRMT5, and the silencing of PRMT5 decreased the mRNA and protein levels of FGFR3 in the 5-8F and CNE2 cells. Silencing of FGFR3 induced similar phenotypes as the inhibition of PRMT5, and re-expression of FGFR3 in 5-8F/shPRMT5 and CNE2/shPRMT5 cells restored the proliferation and colony formation ability induced by irradiation exposure. Our results indicate that PRMT5 is a marker of poor prognosis in NPC patients. PRMT5 promoted the radioresistance of NPC cells via targeting FGFR3, at least partly if not totally. PRMT5 and its downstream effector FGFR3 may be potential targets for anticancer strategy.

View Figures

View References

1	Wei WI and Sham JS: Nasopharyngeal carcinoma. Lancet. 365:2041–2054. 2005. View Article : Google Scholar : PubMed/NCBI
2	Guo P, Huang ZL, Yu P and Li K: Trends in cancer mortality in China: An update. Ann Oncol. 23:2755–2762. 2012. View Article : Google Scholar : PubMed/NCBI
3	Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
4	Lo KW, Chung GT and To KF: Acquired genetic and epigenetic alterations in nasopharyngeal carcinoma. Nasopharyngeal Carcinoma. Busson P: Springer; New York: pp. 61–81. 2013, View Article : Google Scholar
5	Hildesheim A and Wang CP: Genetic predisposition factors and nasopharyngeal carcinoma risk: A review of epidemiological association studies, 2000–2011: Rosetta Stone for NPC: Genetics, viral infection, and other environmental factors. Semin Cancer Biol. 22:107–116. 2012. View Article : Google Scholar : PubMed/NCBI
6	West RB: Fingerprints of Epstein-Barr virus in nasopharyngeal carcinoma. Nat Genet. 46:809–810. 2014. View Article : Google Scholar : PubMed/NCBI
7	Polesel J, Serraino D, Negri E, Barzan L, Vaccher E, Montella M, Zucchetto A, Garavello W, Franceschi S, La Vecchia C, et al: Consumption of fruit, vegetables, and other food groups and the risk of nasopharyngeal carcinoma. Cancer Causes Control. 24:1157–1165. 2013. View Article : Google Scholar : PubMed/NCBI
8	Yoshizaki T, Ito M, Murono S, Wakisaka N, Kondo S and Endo K: Current understanding and management of nasopharyngeal carcinoma. Auris Nasus Larynx. 39:137–144. 2012. View Article : Google Scholar
9	Bensouda Y, Kaikani W, Ahbeddou N, Rahhali R, Jabri M, Mrabti H, Boussen H and Errihani H: Treatment for metastatic nasopharyngeal carcinoma. Eur Ann Otorhinolaryngol Head Neck Dis. 128:79–85. 2011. View Article : Google Scholar
10	Yu F and Loh KS: Cancer stem cells in nasopharyngeal carcinoma: Current evidence. JNPC. 1:e62014. View Article : Google Scholar
11	Zentner GE and Henikoff S: Regulation of nucleosome dynamics by histone modifications. Nat Struct Mol Biol. 20:259–266. 2013. View Article : Google Scholar : PubMed/NCBI
12	Waldmann T and Schneider R: Targeting histone modifications - epigenetics in cancer. Curr Opin Cell Biol. 25:184–189. 2013. View Article : Google Scholar : PubMed/NCBI
13	Greer EL and Shi Y: Histone methylation: A dynamic mark in health, disease and inheritance. Nat Rev Genet. 13:343–357. 2012. View Article : Google Scholar : PubMed/NCBI
14	Chung S, Sundar I, Rahman I and Yao H: Cigarette smoke causes a residue-specific histone methylation and its cross-talk with histone acetylation in human lung epithelial cells. Am J Respir Crit Care Med. 185:A34742012.
15	Eram MS, Bustos SP, Lima-Fernandes E, Siarheyeva A, Senisterra G, Hajian T, Chau I, Duan S, Wu H, Dombrovski L, et al: Trimethylation of histone H3 lysine 36 by human methyltransferase PRDM9 protein. J Biol Chem. 289:12177–12188. 2014. View Article : Google Scholar : PubMed/NCBI
16	Tang H, Fang H, Yin E, Brasier AR, Sowers LC and Zhang K: Multiplexed parallel reaction monitoring targeting histone modifications on the QExactive mass spectrometer. Anal Chem. 86:5526–5534. 2014. View Article : Google Scholar : PubMed/NCBI
17	Di Lorenzo A and Bedford MT: Histone arginine methylation. FEBS Lett. 585:2024–2031. 2011. View Article : Google Scholar
18	Berrens RV and Reik W: Prmt5: A guardian of the germline protects future generations. EMBO J. 34:689–690. 2015. View Article : Google Scholar : PubMed/NCBI
19	Kim S, Günesdogan U, Zylicz JJ, Hackett JA, Cougot D, Bao S, Lee C, Dietmann S, Allen GE, Sengupta R, et al: PRMT5 protects genomic integrity during global DNA demethylation in primordial germ cells and preimplantation embryos. Mol Cell. 56:564–579. 2014. View Article : Google Scholar : PubMed/NCBI
20	Chu Z, Niu B, Zhu H, He X, Bai C, Li G and Hua J: PRMT5 enhances generation of induced pluripotent stem cells from dairy goat embryonic fibroblasts via down-regulation of p53. Cell Prolif. 48:29–38. 2015. View Article : Google Scholar
21	Ibrahim R, Matsubara D, Osman W, Morikawa T, Goto A, Morita S, Ishikawa S, Aburatani H, Takai D, Nakajima J, et al: Expression of PRMT5 in lung adenocarcinoma and its significance in epithelial-mesenchymal transition. Hum Pathol. 45:1397–1405. 2014. View Article : Google Scholar : PubMed/NCBI
22	Zhang B, Dong S, Zhu R, Hu C, Hou J, Li Y, Zhao Q, Shao X, Bu Q, Li H, et al: Targeting protein arginine methyltransferase 5 inhibits colorectal cancer growth by decreasing arginine methylation of eIF4E and FGFR3. Oncotarget. 6:22799–22811. 2015. View Article : Google Scholar : PubMed/NCBI
23	Li G, Liu Y, Su Z, Ren S, Zhu G, Tian Y and Qiu Y: MicroRNA-324-3p regulates nasopharyngeal carcinoma radioresistance by directly targeting WNT2B. Eur J Cancer. 49:2596–2607. 2013. View Article : Google Scholar : PubMed/NCBI
24	Li G, Wang Y, Liu Y, Su Z, Liu C, Ren S, Deng T, Huang D, Tian Y and Qiu Y: miR-185-3p regulates nasopharyngeal carcinoma radioresistance by targeting WNT2B in vitro. Cancer Sci. 105:1560–1568. 2014. View Article : Google Scholar : PubMed/NCBI
25	Chua DT, Nicholls JM, Sham JS and Au GK: Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys. 59:11–20. 2004. View Article : Google Scholar : PubMed/NCBI
26	Lin DC, Meng X, Hazawa M, Nagata Y, Varela AM, Xu L, Sato Y, Liu LZ, Ding LW, Sharma A, et al: The genomic landscape of nasopharyngeal carcinoma. Nat Genet. 46:866–871. 2014. View Article : Google Scholar : PubMed/NCBI
27	Yang F, Qian X-J, Qin W, Deng R, Wu XQ, Qin J, Feng GK and Zhu XF: Dual phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 has a therapeutic potential and sensitizes cisplatin in nasopharyngeal carcinoma. PLoS One. 8:e598792013. View Article : Google Scholar : PubMed/NCBI
28	Pan Y, Zhang Q, Atsaves V, Yang H and Claret FX: Suppression of Jab1/CSN5 induces radio- and chemo-sensitivity in nasopharyngeal carcinoma through changes to the DNA damage and repair pathways. Oncogene. 32:2756–2766. 2013. View Article : Google Scholar :
29	Agaoglu FY, Dizdar Y, Dogan O, Alatli C, Ayan I, Savci N, Tas S, Dalay N and Altun M: p53 overexpression in nasopharyngeal carcinoma. In Vivo. 18:555–560. 2004.PubMed/NCBI
30	Dolcet X, Llobet D, Pallares J and Matias-Guiu X: NF-kB in development and progression of human cancer. Virchows Arch. 446:475–482. 2005. View Article : Google Scholar : PubMed/NCBI
31	Shi D, Guo W, Chen W, Fu L, Wang J, Tian Y, Xiao X, Kang T, Huang W and Deng W: Nicotine promotes proliferation of human nasopharyngeal carcinoma cells by regulating α7AChR, ERK, HIF-1α and VEGF/PEDF signaling. PLoS One. 7:e438982012. View Article : Google Scholar
32	Liu Y, Chen LH, Yuan YW, Li QS, Sun AM and Guan J: Activation of AKT is associated with metastasis of nasopharyngeal carcinoma. Tumour Biol. 33:241–245. 2012. View Article : Google Scholar
33	Tai HC, Huang HY, Lee SW, Lin CY, Sheu MJ, Chang SL, Wu LC, Shiue YL, Wu WR, Lin CM, et al: Associations of Rsf-1 overexpression with poor therapeutic response and worse survival in patients with nasopharyngeal carcinoma. J Clin Pathol. 65:248–253. 2012. View Article : Google Scholar
34	Gu Z, Gao S, Zhang F and Wang Z, Ma W, Davis RE and Wang Z: Protein arginine methyltransferase 5 is essential for growth of lung cancer cells. Biochem J. 446:235–241. 2012. View Article : Google Scholar : PubMed/NCBI